Skip to main content
. 2019 Sep 20;10:878. doi: 10.3389/fgene.2019.00878

Figure 4.

Figure 4

Evaluation of the diagnostic value of hsa_circ_0001821 in gastric cancer (GC) patients. (A) Receiver operating characteristic (ROC) analysis of hsa_circ_0001821 in differentiating GC tissues from noncancerous tissues (n = 80). (B) Detection of circulating hsa_circ_0001821 expression in the whole-blood samples from GC patients (n = 30) and healthy donors (n = 30). (C) The construction of the joint diagnostic model containing circulating hsa_circ_0001821 and existing laboratory indicators. ****P<0.0001 was considered significant.